GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

Rhea-AI Summary

GRAIL (Nasdaq: GRAL) said company management will present at the TD Cowen 46th Annual Health Care Conference in Boston on Mar. 3, 2026 at 10:30 a.m. ET.

Live and replay webcasts will be available via the company's investor relations website and archived for at least 30 days after the event.

Key Figures

Conference date: March 3 Presentation time: 10:30 a.m. ET Webcast availability: 30 days

3 metrics

Conference date March 3 TD Cowen 46th Annual Health Care Conference presentation date

Presentation time 10:30 a.m. ET Scheduled time for management presentation

Webcast availability 30 days Archived replay period after the event

Market Reality Check

Price: $50.35 Vol: Volume 5,385,287 is 3.04x...

high vol

$50.35 Last Close

Volume Volume 5,385,287 is 3.04x the 20-day average of 1,771,853, indicating elevated trading before this routine conference update. high

Technical Shares at 43.03 are trading below the 200-day MA of 64.62 and sit well under the 118.84 52-week high.

Peers on Argus

GRAL fell 14.3% while peers showed mixed, smaller moves (e.g., OPK -3.36%, NEO +...

GRAL fell 14.3% while peers showed mixed, smaller moves (e.g., OPK -3.36%, NEO +1.94%, TWST +1.34%). No peers appeared in the momentum scanner, pointing to stock-specific pressure.

Common Catalyst One peer, CareDx (CDNA), reported earnings, but there is no broad diagnostics conference-related or sector-wide headline pattern matching this GRAL move.

Historical Context

5 past events · Latest: Feb 19 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 19	Earnings update	Neutral	-3.2%	Reported 2025 results with revenue growth but sizable net losses and cash runway.
Feb 19	Clinical trial data	Neutral	-3.2%	Released NHS-Galleri topline data with mixed endpoint outcome and detection benefits.
Jan 29	Regulatory submission	Positive	-3.1%	Submitted final PMA module to FDA for Galleri multi-cancer early detection test.
Dec 15	Conference presentation	Neutral	-4.4%	Planned corporate update at the 44th Annual J.P. Morgan Healthcare Conference.
Dec 01	Equity compensation	Neutral	-0.9%	Announced inducement RSU grants to recent hires under Nasdaq Listing Rule 5635(c)(4).

Pattern Detected

Across the last five news events, GRAL’s shares showed negative next-day reactions to both clinical, earnings, and routine corporate updates, suggesting a pattern of selling into news.

Recent Company History

Recent GRAL news highlighted execution and pipeline progress. On Feb 19, 2026, the company reported Q4 and full-year 2025 results with $147.2M revenue and a narrowed net loss, alongside completion of its Galleri PMA submission and landmark NHS-Galleri data; the stock fell about 3%. Earlier in Jan 2026, GRAL announced the FDA PMA submission for Galleri, also followed by a modest decline. Even routine items like a J.P. Morgan conference presentation and inducement grants in late 2025 saw small negative reactions, framing today’s conference announcement in a pattern of post-news weakness.

Market Pulse Summary

This announcement outlines GRAIL’s upcoming presentation at the TD Cowen health care conference on M...

Analysis

This announcement outlines GRAIL’s upcoming presentation at the TD Cowen health care conference on March 3 at 10:30 a.m. ET, with a webcast available for at least 30 days. In context, the company recently reported 2025 financials, advanced its Galleri PMA submission, and released NHS-Galleri data, so investors may focus more on any incremental commentary at the conference than on the scheduling itself. Attention may center on revenue trends, loss trajectory, and regulatory progress already described in prior filings.

AI-generated analysis. Not financial advice.

MENLO PARK, Calif., Feb. 24, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 46th Annual Health Care Conference in Boston on Tuesday, Mar. 3 at 10:30 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-td-cowen-46th-annual-health-care-conference-302696206.html

SOURCE GRAIL, Inc.

FAQ

When will GRAIL (GRAL) present at the TD Cowen 46th Annual Health Care Conference?

GRAIL will present on Mar. 3, 2026 at 10:30 a.m. ET. According to GRAIL, company management is scheduled to speak at the TD Cowen conference in Boston, providing an investor update and answering questions during the session.

How can investors watch the GRAIL (GRAL) presentation on Mar. 3, 2026?

Investors can watch via a live webcast on GRAIL's investor website. According to GRAIL, the company will stream the presentation live and provide a replay accessible in the investor relations section for viewing convenience.

Will the GRAIL (GRAL) webcast be available after the TD Cowen conference?

Yes, the webcast will be archived and available for at least 30 days after the event. According to GRAIL, investors can access the replay on the investor relations site for follow-up viewing and review of the presentation materials.

Where on the web can I find the GRAIL (GRAL) conference webcast and replay?

The webcast and replay will be posted on GRAIL's investor relations website at investors.grail.com. According to GRAIL, the investor relations section will host the live stream and archive the replay for at least 30 days.

What time zone is the Mar. 3, 2026 GRAIL (GRAL) presentation scheduled in?

The presentation is scheduled for 10:30 a.m. ET on Mar. 3, 2026. According to GRAIL, the stated time refers to Eastern Time for investor planning and webcast scheduling purposes.

Will GRAIL (GRAL) management cover forward-looking guidance during the TD Cowen presentation?

The announcement confirms a management presentation but does not specify content or guidance. According to GRAIL, the session will present company updates; investors should view the webcast for any commentary on strategy or outlook.